• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Barriers to Colonoscopy in an Uninsured Patient Population-A Quality Improvement Project.

作者信息

Wagner Maxwell S, Burgess Jessica, Britt Rebecca C

出版信息

Am Surg. 2019 Jan 1;85(1):111-114.

PMID:30760355
Abstract

Colorectal cancer remains common, with the "80 per cent by 2018" initiative proposed by the National Colorectal Cancer Roundtable. This study was designed to examine obstacles for patients who did not receive their scheduled colonoscopy, focusing on the impact of insurance status. Retrospective chart review was carried out on patients who did not complete their colonoscopy as scheduled from January 2013 to June 2017. The control group consisted of patients who completed their scheduled colonoscopy. One hundred and seventy five patients missed 200 colonoscopies. The most common reasons for cancellation were patient illness (16%), no-show (14%), no prep carried out (13%), inadequate prep (10%), and no transportation (11%). The canceled patients were significantly more likely to have the combination of no insurance and no Primary Care Provider (PCP) (13% 4%, = 0.008), personal history of cancer (22% 12%, = 0.02), and higher rates of prior GI issues (78% 50%, < 0.001). The canceled group had a significantly lower history of colon polyps (37% 53%, = 0.006). Difficulty with the bowel prep in addition to lack of insurance and poverty likely does create a barrier, even in a system that has a safety net, atop other issues such as transportation and inability to miss work playing a role.

摘要

相似文献

1
Barriers to Colonoscopy in an Uninsured Patient Population-A Quality Improvement Project.
Am Surg. 2019 Jan 1;85(1):111-114.
2
Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting.在城市公立医院环境中评估一项增加结肠镜筛查的干预措施。
J Urban Health. 2006 Mar;83(2):231-43. doi: 10.1007/s11524-006-9029-6.
3
Barriers to colonoscopy in remote northern Canada: an analysis of cancellations.加拿大偏远北部地区结肠镜检查的障碍:取消原因分析。
Int J Circumpolar Health. 2020 Dec;79(1):1816678. doi: 10.1080/22423982.2020.1816678.
4
Open access colonoscopy: Critical appraisal of indications, quality metrics and outcomes.开放式结肠镜检查:对适应证、质量指标及结果的批判性评估
Dig Liver Dis. 2016 Aug;48(8):940-4. doi: 10.1016/j.dld.2016.04.005. Epub 2016 Apr 16.
5
Colon cancer screening for Colorado's underserved: a community clinic/academic partnership.科罗拉多州服务不足人群的结肠癌筛查:社区诊所/学术合作。
Am J Prev Med. 2015 Mar;48(3):264-70. doi: 10.1016/j.amepre.2014.09.016. Epub 2014 Dec 26.
6
Expanding Access to Colorectal Cancer Screening: Benchmarking Quality Indicators in a Primary Care Colonoscopy Program.扩大结直肠癌筛查的可及性:基层医疗结肠镜检查项目中的质量指标基准
J Am Board Fam Med. 2015 Nov-Dec;28(6):713-21. doi: 10.3122/jabfm.2015.06.140342.
7
Appointment-keeping behaviors and procedure day are associated with colonoscopy attendance in a patient navigator population.预约行为和检查日与患者导航人群的结肠镜检查出勤率相关。
Prev Med. 2017 Apr;97:8-12. doi: 10.1016/j.ypmed.2016.12.022. Epub 2016 Dec 23.
8
Colonoscopy completion in a large safety net health care system.在一个大型安全网医疗保健系统中完成结肠镜检查。
Clin Gastroenterol Hepatol. 2008 Apr;6(4):438-42. doi: 10.1016/j.cgh.2007.12.003. Epub 2008 Mar 4.
9
Colonoscopy bowel preparation quality improvement for patients with decompensated cirrhosis undergoing evaluation for liver transplantation.对接受肝移植评估的失代偿期肝硬化患者进行结肠镜检查肠道准备质量的改善。
Clin Transplant. 2016 Oct;30(10):1236-1241. doi: 10.1111/ctr.12809.
10
Low-Value Medical Services in the Safety-Net Population.安全网人群中的低价值医疗服务。
JAMA Intern Med. 2017 Jun 1;177(6):829-837. doi: 10.1001/jamainternmed.2017.0401.

引用本文的文献

1
Optimizing tracking and completion of follow-up colonoscopy after abnormal stool tests at health systems participating in the Centers for Disease Control and Prevention's Colorectal Cancer Control Program.优化在参与疾病控制与预防中心结直肠癌控制计划的卫生系统中,对粪便检查异常后的结肠镜检查随访的跟踪和完成。
Cancer Causes Control. 2024 Nov;35(11):1467-1476. doi: 10.1007/s10552-024-01898-w. Epub 2024 Aug 6.
2
A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice.一种非系统性磷酸二酯酶-5 抑制剂可抑制小鼠结肠增殖。
Int J Mol Sci. 2023 May 28;24(11):9397. doi: 10.3390/ijms24119397.
3
Reach and effectiveness of a centralized navigation program for patients with positive fecal immunochemical tests requiring follow-up colonoscopy.
针对粪便免疫化学检测呈阳性且需要后续结肠镜检查的患者的集中式导航计划的覆盖范围和有效性。
Prev Med Rep. 2023 Apr 17;34:102211. doi: 10.1016/j.pmedr.2023.102211. eCollection 2023 Aug.
4
The enduring promise of phosphodiesterase 5 inhibitors for colon cancer prevention.磷酸二酯酶5抑制剂在预防结肠癌方面的持久前景。
Transl Gastroenterol Hepatol. 2019 Dec 23;4:83. doi: 10.21037/tgh.2019.12.10. eCollection 2019.